Key Metrics
CiteScore 

2.9
H-Index 

17
SJR 

Q2Pharmacology

SNIP 

0.78
Recommended pre-submission checks
Powered by 

Topics Covered on PharmacoEconomics - Open
PharmacoEconomics - Open Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | SPRINGER INT PUBL AG |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 2790 | USD 3490 | GBP 2390 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in PharmacoEconomics - Open ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in PharmacoEconomics - Open
Adverse Drug Reaction Costs and Study Quality in Africa: A Systematic Review of Cost-of-Illness Studies.
- 19 May 2026
- PharmacoEconomics - open
Economic Burden of Spinal Muscular Atrophy in Singapore: A Societal Perspective Cost-of-Illness Study.
- 8 May 2026
- PharmacoEconomics - open
Estimating Eligibility for Lung Cancer Screening in Ireland: A Dynamic Modelling Study of Smoking Trends.
- 4 May 2026
- PharmacoEconomics - open
Advancing Lost Productivity Measurement in Economic Evaluations: Evidence Priorities from a Targeted Literature Review and Expert Workshop.
- 3 May 2026
- PharmacoEconomics - open
Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?
- 21 Apr 2026
- PharmacoEconomics - open
Updated Health Economics Simulation Model of the Lifetime Progression of Multiple Sclerosis in an Australian Setting.
- 16 Apr 2026
- PharmacoEconomics - open
Adverse Drug Reaction Costs and Study Quality in Africa: A Systematic Review of Cost-of-Illness Studies.
- 19 May 2026
- PharmacoEconomics - open
Economic Burden of Spinal Muscular Atrophy in Singapore: A Societal Perspective Cost-of-Illness Study.
- 8 May 2026
- PharmacoEconomics - open
Estimating Eligibility for Lung Cancer Screening in Ireland: A Dynamic Modelling Study of Smoking Trends.
- 4 May 2026
- PharmacoEconomics - open
Advancing Lost Productivity Measurement in Economic Evaluations: Evidence Priorities from a Targeted Literature Review and Expert Workshop.
- 3 May 2026
- PharmacoEconomics - open
Correction: Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?
- 21 Apr 2026
- PharmacoEconomics - open
Updated Health Economics Simulation Model of the Lifetime Progression of Multiple Sclerosis in an Australian Setting.
- 16 Apr 2026
- PharmacoEconomics - open